News

Semprus is the developer of a new technology platform aimed at reducing medical device complications in areas of infections, thrombus, restenosis and bone integration. The company has previously

In 2004, based on results of Intergroup Exemestane Study the Team trial design was revised; the tamoxifen arm was converted into a tamoxifen/Aromasin sequencing arm. This analysis represents

The company has also announced that Lawrence Kenyon will join Par on December 15, 2008 as executive vice president of finance and will assume the role of CFO

According to the company, this represents the first and only approved Pegintron in combination with Rebetol for treating pediatric hepatitis C. Rebetol is available both as capsules and

The objectives of the double-blind, randomized, placebo-controlled multiple dose Phase Ib study were to determine safety and tolerance when adding ALX-0081 via intravenous administration to a standard anti-thrombotic

Ciprofloxacin HCl ophthalmic solution is indicated for the treatment of infections caused by microorganisms in corneal ulcers and conjunctivitis. Akorn expects to launch ciprofloxacin in 2009. Arthur Przybyl,

Isentress is approved for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-experienced adult patients who have evidence of viral replication and

BridgeGate has granted Healthation a non-exclusive license to incorporate the BridgeGate integration platform within Healthation’s AcceleHealth real-time benefit management system and AboveHealth EHealth suite. Healthation’s AcceleXchange, an integration

Nimotuzumab is currently being advanced in several randomized Phase II and III trials in Japan, Europe and elsewhere and is undergoing an YM-sponsored confirmatory trial in pediatric glioma